Exelixis Inc (EXEL.O)

EXEL.O on Nasdaq

3.11USD
17 Apr 2015
Change (% chg)

$0.01 (+0.32%)
Prev Close
$3.10
Open
$3.10
Day's High
$3.14
Day's Low
$3.03
Volume
1,719,650
Avg. Vol
3,900,477
52-wk High
$4.55
52-wk Low
$1.26

EXEL.O

Chart for EXEL.O

About

Exelixis, Inc., is a biotechnology company. The Company is engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing on resources, development and commercialization of COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC) in the United... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $609.32
Shares Outstanding(Mil.): 195.92
Dividend: --
Yield (%): --

Financials

  EXEL.O Industry Sector
P/E (TTM): -- 157.03 41.57
EPS (TTM): -1.38 -- --
ROI: -93.97 -0.84 16.05
ROE: -- -2.80 16.88
Search Stocks

Competitors

  Price Chg
AstraZeneca plc (AZN.L) 4,750.00p -78.50
Pfizer Inc. (PFE.N) $35.04 -0.15
ArQule, Inc. (ARQL.OQ) $2.14 -0.03
GlaxoSmithKline plc (GSK.L) 1,575.50p -20.50
Algeta ASA (ALGETA.OL) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks